Yu-Hsuan Shih
Overview
Explore the profile of Yu-Hsuan Shih including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Syeed S, Tan C, Godara A, Gooden K, Tang D, Slaff S, et al.
Pharmacoeconomics
. 2024 Dec;
PMID: 39643805
Background: Although innovation generally provides measurable improvements in disease characteristics and patient survival, some benefits can remain unclear. This study aimed to investigate patient and healthcare provider (HCP) preferences for...
2.
Anwer F, Lan T, Dolph M, Moradian H, Slaff S, Shih Y, et al.
Future Oncol
. 2024 Nov;
21(2):221-230.
PMID: 39611661
Aims: Limited head-to-head data exist for daratumumab plus pomalidomide and dexamethasone (DPd) and non-pomalidomide-containing triplet regimens to treat relapsed/refractory multiple myeloma (RRMM). This study conducted population-adjusted indirect comparisons of overall...
3.
Liao P, Lu H, Chen T, Lin H, Shih Y, Teng C
Cancer Rep (Hoboken)
. 2024 May;
7(5):e2102.
PMID: 38775249
Background: Thalidomide-containing regimens cause adverse events (AEs) that may require a reduction in treatment intensity or even treatment discontinuation in patients with multiple myeloma. As thalidomide toxicity is dose-dependent, identifying...
4.
Tseng K, Hsu C, Shih Y, Lin H, Li Y, Teng C, et al.
Ther Adv Med Oncol
. 2024 May;
16:17588359241247019.
PMID: 38716478
Background: The limited efficacy of chemotherapy in improving survival in pancreatic ductal adenocarcinoma (PDAC) necessitates the exploration of novel strategies to overcome treatment resistance. Objectives: This study aimed to investigate...
5.
Shih Y, Lin H, Liao P, Chou C, Lin C, Hsu C, et al.
BMC Cancer
. 2023 Aug;
23(1):770.
PMID: 37596599
Background: Adjuvant chemotherapy is recommended as the standard treatment for patients with stage II/III resected gastric cancer. However, it is unclear whether older patients also benefit from an adjuvant chemotherapy...
6.
Weiss M, Shih Y, Scannell Bryan M, Jackson B, Aguilar D, Brown E, et al.
Environ Adv
. 2023 Jul;
12.
PMID: 37426694
Background: Differences in arsenic metabolism capacity may influence risk for type 2 diabetes, but the mechanistic drivers are unclear. We evaluated the associations between arsenic metabolism with overall diabetes prevalence...
7.
Grandjean P, Shih Y, Helskov Jorgensen L, Nielsen F, Weihe P, Budtz-Jorgensen E
Pediatr Res
. 2023 Jun;
94(5):1832-1837.
PMID: 37316707
Background: Perfluoroalkyl substances (PFASs) are transferred through human milk and may cause elevated exposure during infancy. Given the lack of early postnatal blood samples, PFAS concentrations can be estimated to...
8.
Lai C, Lin C, Su Y, Shih Y, Wang C, Teng C, et al.
Cancer Med
. 2022 Nov;
12(6):6802-6810.
PMID: 36426417
Background: Hepatitis B virus (HBV) affects the occurrence and survival outcome of various malignant disorders. The study aimed to evaluate the survival outcome of head and neck squamous cell cancer...
9.
Liao P, Cheng S, Chou C, Lin H, Lin C, Chen T, et al.
Clin Med Insights Oncol
. 2022 Sep;
16:11795549221123617.
PMID: 36134036
Background: Palliative chemotherapy is the preferred standard of care for patients with metastatic gastric cancer (mGC). It remains uncertain whether older patients with mGC would benefit from palliative chemotherapy. This...
10.
Chen H, Shih Y, Wang H, Sun Y, Wang R, Teng C
J Biophotonics
. 2022 Sep;
15(12):e202200143.
PMID: 36053802
It is unclear whether a hyperspectral imaging-based approach can facilitate the diagnosis of diffuse large B-cell lymphoma (DLBCL), and further investigation is required. In this study, the pixel purity index...